Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial-Reference-Cited by-同舟云学术

Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial

Published:2013-05 Issue:3 Volume:11 Page:175-183
ISSN:2095-4964
Container-title:Journal of Integrative Medicine
language:en
Short-container-title:Journal of Integrative Medicine

Author:

Wang Tian-zhan,Chen Yu,He Yan-ming,Fu Xiao-dong,Wang Yi,Xu Yan-qiu,Yang Hong-jie,Xue Hong-li,Liu Yi,Feng Xiao-tao,Zhang Teng,Wang Wen-jian

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation;Alberti;Diabet Med,1998

2. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines;Schrijvers;Endocr Rev,2004

3. Microalbuminuria;Khosla;Clin Lab Med,2006

4. Clinical research of Yiqi Sanju Formula in treating central obese men at high risk of metabolic syndrome;He;J Chin Integr Med,2007

5. Effects of Yiqi Sanju Formula on nonalcoholic fatty liver disease: a randomized controlled trial;Lou;J Chin Integr Med,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabetic Mice with Nephropathy;Journal of Diabetes Research;2024-01-20

2. Huajuxiaoji Formula Alleviates Phenyl Sulfate‐Induced Diabetic Kidney Disease by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis;Journal of Diabetes Research;2024-01

3. Effectiveness of Chinese herbal medicine compared with angiotensin II receptor blockers in patients with diabetic kidney disease: A hospital-based matched cohort study;Journal of Traditional and Complementary Medicine;2023-11

4. Oral Chinese patent medicines for diabetic kidney disease: An overview of systematic reviews;European Journal of Integrative Medicine;2023-08

5. Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis;Drug Design, Development and Therapy;2022-04